Primary Health Management for Chronic Obstructive Pulmonary Disease

Not Applicable

Active, not recruiting

• Conditions: Pulmonary Disease; Chronic Obstructive Pulmonary Disease

• Registration Number: NCT06573580
• Lead Sponsor: China-Japan Friendship Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-7-26
• Last Update Posted: 2 September 2024

Recruitment & Eligibility

• Status: Active, not recruiting
• Sex: All
• Target Recruitment: 6000

Inclusion Criteria

Inclusion Criteria:<br><br> 1. Age = 35 years.<br><br> 2. Diagnosis of Chronic Obstructive Pulmonary Disease (COPD) according to the 2024 GOLD<br> guidelines.<br><br> 3. Post-bronchodilator FEV1(Forced Expiratory Volume in one second) predicted = 30%.<br><br>Exclusion Criteria:<br><br> 1. Inability to provide informed consent.<br><br> 2. Contraindications for pulmonary function tests, including:<br><br> - Recent myocardial infarction, stroke, or shock within the past 3 months.<br><br> - Severe heart failure, severe arrhythmias, or unstable angina within the past 4<br> weeks.<br><br> - Recent major hemoptysis within the past 4 weeks.<br><br> - Major thoracic, abdominal, or ophthalmic surgery within the past 3 months.<br><br> - Psychiatric disorders requiring antipsychotic medication or with a history of<br> seizures requiring medication.<br><br> - Cognitive impairment, including dementia or severe comprehension deficits.<br><br> - Uncontrolled hypertension (systolic blood pressure > 200 mmHg, diastolic blood<br> pressure > 100 mmHg).<br><br> - Resting heart rate > 120 beats per minute.<br><br> - Presence of aortic aneurysm.<br><br> - Severe hyperthyroidism.<br><br> - Pregnancy or lactation.<br><br> - Respiratory tract infections (e.g., tuberculosis, influenza, pneumonia) within<br> the past month.<br><br> - Presence of pneumothorax, large pulmonary bullae not scheduled for surgery, or<br> tympanic membrane perforation.<br><br> 3. Currently participating in, or planning to participate in, any other COPD health<br> management or clinical intervention projects during the study period.

Exclusion Criteria

Not provided

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Acute exacerbation frequency;Self-rated Quality of Life

Secondary Outcome Measures

Name	Time	Method
Change in lung function;Degree of dyspnea (daily activity);Oxygen desaturation